Disease Progression in HIV-1-Infected Viremic Controllers. - Wikidata - wikimedia - TriplyDB

Disease Progression in HIV-1-Infected Viremic Controllers.

Disease Progression in HIV-1-Infected Viremic Controllers.

http://www.wikidata.org/entity/Q37077305

about

A Subset of Extreme Human Immunodeficiency Virus (HIV) Controllers Is Characterized by a Small HIV Blood Reservoir and a Weak T-Cell Activation Level.Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals.The natural history of HIV infection.Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics.Immunologic and Virologic Progression in HIV Controllers: The Role of Viral "Blips" and Immune Activation in the ANRS CO21 CODEX Study.HIV Replication at Low Copy Number and its Correlation with the HIV Reservoir: A Clinical Perspective.Virological and immunological characteristics of HIV-infected individuals at the earliest stage of infection HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART.Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals.Long-Term Non-Progression and Broad HIV-1-Specific Proliferative T-Cell Responses.Loss of long-term non-progressor and HIV controller status over time in the French Hospital Database on HIV - ANRS CO4.High Plasma Levels of sTNF-R1 and CCL11 Are Related to CD4+ T-Cells Fall in Human Immunodeficiency Virus Elite Controllers With a Sustained Virologic Control.

P2860

Q33745355-543D4327-4DFC-41FD-B2B9-5D63CADCEE26 Q34105477-91EE4A1D-DC21-4522-90DC-886B8CCB8C3F Q34337675-15F22122-FCF8-4864-A367-3E64C1383500 Q35408098-46A9CBB7-0211-4FA0-A7A7-0FA833368FEF Q35683067-8229E8D2-71F7-46D8-919B-A6FD58F732D3 Q35698144-37B215BE-C3DB-4876-8700-EA189D850397 Q36581887-6D57F906-BD03-4C49-97EE-C39BB8481B14 Q37309464-83F9CE98-1579-4829-90DC-B5D8094C73B7 Q37713470-03E9C5CC-F6CD-4693-8129-EDFF6BC58ACD Q38086432-D805B8DF-A3DD-4615-BCA6-40FAAC7B0CA9 Q41926712-F91CD907-A643-440B-B10C-844843D0E554 Q55400910-75E85894-5AC1-45D3-AD4E-47934CE3C488

P2860

Disease Progression in HIV-1-Infected Viremic Controllers.

http://www.wikidata.org/entity/Q37077305

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Disease Progression in HIV-1-Infected Viremic Controllers.

@en

Disease Progression in HIV-1-Infected Viremic Controllers.

@nl

type

label

Disease Progression in HIV-1-Infected Viremic Controllers.

@en

Disease Progression in HIV-1-Infected Viremic Controllers.

@nl

prefLabel

Disease Progression in HIV-1-Infected Viremic Controllers.

@en

Disease Progression in HIV-1-Infected Viremic Controllers.

@nl

P1433

Q37077305-DCA2EDC1-4CA3-4261-B23C-0C70D39B5B44

P1476

Q37077305-AE40A0BB-8656-4F06-A026-C3BD3A637ECE

P2093

Q37077305-41AC00B6-F53F-4246-B730-0FD942FF5298

Q37077305-811B3AC1-5355-42E3-B525-A906349CA30D

Q37077305-962EA11A-942C-4B38-A72D-A1BDF59D57A2

Q37077305-98A52B3C-B328-4D52-9EF7-28AFB22EDA70

Q37077305-A2EF4029-D808-4E2E-AFD6-F8EDA8B2F622

Q37077305-BC8991E6-711A-4F1A-894D-0F3AD9B7273F

P2860

Q37077305-0A246E0B-8031-45DD-B5E5-936FB9475A36

Q37077305-16839BF7-40C1-4BEF-85F9-1328C4EAD228

Q37077305-18D22872-D551-47C2-BEFE-7B12D42B218E

Q37077305-18F7449E-C56C-4033-845A-1BB6C94B8D99

Q37077305-1AABDA8F-34BE-4D85-83ED-E1B7C70D2B51

Q37077305-2125549E-AC40-4308-9E15-00C6175226A9

Q37077305-25EE5C30-88C3-4931-93A0-589068EE204D

Q37077305-2BBE8215-72DB-4815-B2FA-D162B4BBF0C1

Q37077305-3E7A10A0-9EA6-424F-A792-BCD5B0E0F89A

Q37077305-51ADC811-A8E3-4BCB-B8D7-024A2238724A

P304

Q37077305-D17F01AA-55AD-4DEB-B98C-212CC5E6160B

P31

Q37077305-1DA09616-D877-42DD-8CAD-914A85BA618F

P356

Q37077305-B33BF2C4-FF3E-4056-8C80-E3563E963DA4

P407

Q37077305-C55F9352-B549-4974-90C5-C3F23CE68C36

P433

Q37077305-2DBB1A35-233C-478B-9242-AC856C051059

P478

Q37077305-ADE71C5D-5EFA-43F7-B9FE-A108BCD41B90

P50

Q37077305-1D197477-C016-49BF-8DD8-8C856717DF68

Q37077305-206D54FB-C722-4470-A2A6-DFD122B5D0A9

Q37077305-7F0D855F-9D0F-4C54-A768-33620D3AF803

P577

Q37077305-05595316-F73C-4A24-A31B-06A34A827407

P5875

Q37077305-CAEF7F92-0283-41B0-8AE1-D75C9447B28B

P698

Q37077305-C5D0265B-2249-441B-97C2-CE1A2C8D9490

P921

Q37077305-90831F26-FABC-4797-AB5E-DB56BF28F9D1

P932

Q37077305-C3E8C52B-6230-4C55-9BEB-2BD8E0E5963E

P356

QAI.0B013E318269C414

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Disease Progression in HIV-1-Infected Viremic Controllers.

@en

P2093

Aine McKnight

http://www.w3.org/2001/XMLSchema#string

Andrew J Stagg

http://www.w3.org/2001/XMLSchema#string

Are Isaksen

http://www.w3.org/2001/XMLSchema#string

Duncan A Clark

http://www.w3.org/2001/XMLSchema#string

Jane R Deayton

http://www.w3.org/2001/XMLSchema#string

Katherine C Groves

http://www.w3.org/2001/XMLSchema#string

P2860

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

Elite control of HIV Infection: implications for vaccines and treatment

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection.

Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues.

Detection of human immunodeficiency virus type 1 DNA in dried blood spots by a duplex real-time PCR assay

Decay kinetics of human immunodeficiency virus-specific CD8+ T cells in peripheral blood after initiation of highly active antiretroviral therapy.

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection.

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

P304

407-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E318269C414

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

61

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230697650

http://www.w3.org/2001/XMLSchema#string

P698

22902723

http://www.w3.org/2001/XMLSchema#string

P921

P932

3736311

http://www.w3.org/2001/XMLSchema#string